Inetetamab
Drug timelines are a Plus or Pro feature.
13 regulatory and trial events tracked for Inetetamab, covering 2020-12-23 to 2025-09-19. Get the full timeline:
Most recent: Clinical Trial Update: SKB264 Plus Inetetamab in HER2-Positive Metastatic Breast Cancer Patients Progressing After T-DXd Treatment [Phase 2]